EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

TRPA1, TRPV1, and Caffeine: Pain and Analgesia

Elizabeth A Puthumana, Luna Muhamad, Lexi A Young, Xiang-Ping Chu iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25147903 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Elizabeth A Puthumana und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Biomedical Sciences, School of Medicine, University of Missouri-Kansas City, Kansas City, MO 64108, USA. Hauptthemen laut MEDLINE: Caffeine, TRPV Cation Channels, TRPA1 Cation Channel, Pain. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Caffeine (1,3,7-trimethylxanthine) is a naturally occurring methylxanthine that acts as a potent central nervous system stimulant found in more than 60 different plants and fruits. Although caffeinated beverages are widely and casually consumed, the application of caffeine beyond dietary levels as pharmacologic therapy has been recognized since the beginning of its recorded use. The analgesic and vasoactive properties of caffeine are well known, but the extent of their molecular basis remains an area of active research. There is existing evidence in the literature as to caffeine’s effect on TRP channels, the role of caffeine in pain management and analgesia, as well as the role of TRP in pain and analgesia; however, there has yet to be a review focused on the interaction between caffeine and TRP channels. Although the influence of caffeine on TRP has been demonstrated in the lab and in animal models, there is a scarcity of data collected on a large scale as to the clinical utility of caffeine as a regulator of TRP. This review aims to prompt further molecular research to elucidate the specific ligand–host interaction between caffeine and TRP by validating caffeine as a regulator of transient receptor potential (TRP) channels—focusing on the transient receptor potential vanilloid 1 (TRPV1) receptor and transient receptor potential ankyrin 1 (TRPA1) receptor subtypes—and its application in areas of pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CaffeineTRPV Cation ChannelsTRPA1 Cation ChannelPainHumansAnimalsAnalgesiaAnalgesics

Stichwörter der Autor:innen

TRPTRPA1TRPV1analgesiacaffeinemethylxanthinepain

Substanzen

CaffeineTRPV Cation ChannelsTRPA1 Cation ChannelAnalgesicsTRPV1 protein, human

Autor:innen und Institutionen

  • Departments of Biomedical Sciences, School of Medicine, University of Missouri-Kansas City, Kansas City, MO 64108, USA.

ORCID-Profile: Xiang-Ping Chu

Zitieren

APA

Puthumana, E. A., Muhamad, L., Young, L. A., & Chu, X. P. (2024). TRPA1, TRPV1, and Caffeine: Pain and Analgesia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147903

Vancouver

Puthumana EA, Muhamad L, Young LA, Chu XP. TRPA1, TRPV1, and Caffeine: Pain and Analgesia. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147903

BibTeX
@article{Puthumana2024,
  author = {Puthumana, Elizabeth A and Muhamad, Luna and Young, Lexi A and Chu, Xiang-Ping},
  title = {TRPA1, TRPV1, and Caffeine: Pain and Analgesia},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25147903}
}
Kostenlos starten →